Because majority of breast cancers are ERα positive and coregulators proved to be crucial for ER transcriptional activity, an increased interest in the field has led to the identification of a large number of coregulators (Lonard and O'malley, 2006). This evidence concerns the gene ESR1 and breast carcinoma.